BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action LawsuitMorningStar·1 day ago, 12:57 AMBBNX-2.51%
Beta Bionics CEO Sean Saint disposes of 5,641 common shares for $113,261.01PUBT·1 day ago, 09:20 PMBBNX-2.51%
Beta Bionics (NASDAQ:BBNX) Insider Sells 4,221 Shares of StockMarket Beat·2 days ago, 11:08 AMBBNX-2.51%
FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Trackingbenzinga_article·Aug 26 at 01:36 PMABT-0.42%MMED-2.33%
Innovative Insulin Pumps Drive Optimism for Tandem, Beta Bionicsbenzinga_article·Aug 21 at 05:31 PMTNDM-2.59%BBNX-2.51%
Beta Bionics (NASDAQ:BBNX) Shares Up 13.7% - Should You Buy?Market Beat·Aug 7 at 06:20 PMBBNX-2.51%BLK-0.34%
Perceptive Advisors LLC Buys 240,000 Shares of Beta Bionics, Inc. $BBNXMarket Beat·Aug 2 at 10:16 AMBBNX-2.51%GS-A-0.23%
BBNX: Q2 revenue up 38% year-over-year, gross margin at 59%, and innovation pipeline advancingQuartr·Jul 29 at 10:46 PMBBNX-2.51%
Beta Bionics | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 32.01 MEarnings Watch·Jul 29 at 08:06 PMBBNX-2.51%
Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 GuidanceUnusual Whales·Jul 29 at 08:04 PMBBNX-2.51%
Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn SituationSimplywall·Jul 28 at 11:15 AMBBNX-2.51%
